← All companies

NRXS

NeurAxis, Inc.

NRXS NYSE Electromedical & Electrotherapeutic Apparatus EDGAR ↗

$6.59

+0.34 +5.44%

Key statistics

from XBRL data in SEC filings

Market cap

$81.6M

Revenue (TTM)

$4.28M

Net income (TTM)

-$7.28M

EPS (TTM)

$-0.80

P/E ratio

—

Dividend yield

—

Free cash flow

-$6.46M

Cash

$7.08M

Total assets

$8.75M

Gross margin

85.0%

52-week range

$2.20 – $9.33

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jul 10, 2026 8-K Shareholder vote results Jun 12, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Other events Apr 22, 2026 8-K Results of operations (earnings release) Apr 21, 2026 10-K Fiscal year ended 2025-12-31 Mar 19, 2026 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Other events Oct 24, 2025 8-K Results of operations (earnings release) Oct 23, 2025 8-K Entered a material agreement Sep 2, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Entered a material agreement; Terminated a material agreement; Director or officer change Jul 3, 2025 8-K Shareholder vote results Jun 4, 2025 8-K Regulation FD disclosure May 28, 2025 8-K Entered a material agreement; Other events May 22, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Other events May 21, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Results of operations (earnings release) Jan 8, 2025 8-K Director or officer change Nov 25, 2024 8-K Modified rights of security holders; Amended charter or bylaws Nov 21, 2024 8-K Entered a material agreement; Unregistered sale of equity Nov 15, 2024 8-K Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Entered a material agreement; Unregistered sale of equity Oct 18, 2024 8-K Unregistered sale of equity Sep 13, 2024 8-K Shareholder vote results Aug 21, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Results of operations (earnings release) Aug 9, 2024 8-K Director or officer change Jul 5, 2024 8-K Entered a material agreement; Took on a direct financial obligation May 28, 2024 10-Q Quarter ended 2024-03-31 May 20, 2024 10-K Fiscal year ended 2023-12-31 Apr 16, 2024 8-K Director or officer change Apr 16, 2024 8-K Results of operations (earnings release); Previously issued financials not reliable Apr 9, 2024 8-K Entered a material agreement Mar 28, 2024 8-K Director or officer change; Regulation FD disclosure Mar 11, 2024 8-K Entered a material agreement; Took on a direct financial obligation Feb 15, 2024 8-K Director or officer change; Regulation FD disclosure Jan 31, 2024 8-K Other events Dec 19, 2023